Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope

Christine Galustian*, Angus Dalgleish, Mark Bodman-Smith, Sergei Kusmartsev, Prokar Dasgupta

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

2 Citations (Scopus)
Original languageEnglish
Article number1021870
JournalFrontiers in oncology
Publication statusPublished - 8 Sept 2022


  • CAR T cell therapy
  • Castration-resistant Prostate Cancer
  • Immunotherapy
  • Prostate Cancer
  • Provenge
  • Tumor microenvironment

Cite this